GlassScriptPhysician profile
Bruce Barry Williams
NPI 1922203371
$1,360.55
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $127 · 2021: $360 · 2022: $265 · 2023: $418 · 2024: $9.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $331 · Food and Beverage: $96.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $331.37 |
| Food and Beverage | $96.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $374.73 | 2020-2023 | Da Vinci Surgical System |
| Aspira Women'S Health INC | $136.59 | 2021-2023 | Ova1 |
| Pfizer INC. | $114.56 | 2019 | |
| Abbvie INC. | $100.42 | 2020-2021 | |
| Organon LLC | $81.67 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $75.76 | 2019-2023 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $67.88 | 2019-2023 | |
| Daiichi Sankyo INC. | $65.87 | 2021-2022 | |
| Exeltis, USA INC. | $52.46 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.46 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $42.59 | 2021-2022 | |
| Heron Therapeutics, INC. | $37.95 | 2021-2022 | |
| Agile Therapeutics, INC. | $36.76 | 2021-2022 | |
| Evofem Biosciences, INC. | $31.38 | 2021 | |
| Smith+Nephew, INC. | $25.10 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $21.33 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $12.97 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.81 | 2020 | |
| Mylan Pharmaceuticals INC. | $11.78 | 2020 | |
| Myovant Sciences INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.